Deciphering the dual nature of the Fibrosis-4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy. | Hepatol Res;54(2): 120-121, 2024 Feb. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Deciphering the dual nature of the Fibrosis-4 index in predicting hepatocellular carcinoma risk among hepatitis B patients undergoing nucleos(t)ide analog therapy.

Arai, Jun; Ito, Kiyoaki.

Affiliation

Arai J; Department of Gastroenterology, Aichi Medical University School of Medicine, Nagakute, Japan.
Ito K; Department of Gastroenterology, Aichi Medical University School of Medicine, Nagakute, Japan.

Hepatol Res ; 54(2): 120-121, 2024 Feb.

Article in En | MEDLINE | ID: mdl-38126190

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hepatol Res Year: 2024 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hepatol Res Year: 2024 Document type: Article Affiliation country: Japan Country of publication: Netherlands